XML 59 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Income taxes (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign

The loss from operations before tax benefit (expense) consisted of the following for the years ended December 31, 2022, 2021, and 2020:

    

2022

    

2021

    

2020

Domestic

$

(591,126)

$

(487,726)

$

(452,475)

Foreign

 

3,639

 

(30,614)

 

49,543

Total

$

(587,487)

$

(518,340)

$

(402,932)

Components of Income Tax Provision

The Income Tax Provision consisted of the following for the years ended December 31, 2022, 2021 and 2020:

    

2022

    

2021

    

2020

Current:

 

  

 

  

 

  

U.S. Federal

$

$

$

U.S. State and Local

 

(4,224)

 

(3,844)

 

(24,984)

Foreign

 

(1,582)

 

(1,340)

 

(4,372)

Deferred:

 

 

  

 

  

U.S. Federal

 

23,689

 

 

U.S. State and Local

 

10,587

 

(377)

 

(5,872)

Foreign

 

 

 

Total tax benefit (expense)

$

28,470

$

(5,561)

$

(35,228)

Schedule of reconciliation of the U.S. statutory income tax rate to the Company's effective tax rate

A reconciliation of the U.S. statutory income tax rate to the Company’s effective tax rate is as follows:

    

December 31, 

 

    

2022

    

2021

    

2020

 

Federal income tax provision at statutory rate

21.00

%  

21.00

%  

21.00

%  

State income tax provision, net of federal benefit

3.07

 

(0.74)

 

(3.31)

 

Permanent differences

(1.83)

 

(4.06)

 

(6.66)

 

Research and development

5.89

 

4.50

 

4.93

 

Change in valuation allowances

(23.36)

 

(29.03)

 

(26.40)

 

Change in deferred tax assets

(0.10)

 

12.05

 

2.93

 

Foreign tax rate differential

(0.17)

 

0.01

 

0.72

 

Tax rate change

0.34

 

0.01

 

(1.46)

 

(Accrual) Release of uncertain tax positions

(4.78)

(0.61)

Other

 

(0.03)

 

0.12

 

Effective income tax rate

4.84

%  

(1.07)

%  

(8.74)

%

Schedule of significant components of the Company's deferred tax assets and liabilities

    

December 31, 

2022

    

2021

Assets:

 

  

 

  

Noncurrent deferred income taxes

$

$

Liabilities:

 

  

 

  

Noncurrent deferred income taxes

 

(102,834)

 

(137,110)

Deferred income taxes - net

$

(102,834)

$

(137,110)

The significant components of the Company’s deferred tax assets and liabilities at December 31, 2022 and 2021 are as follows:

    

2022

    

2021

Deferred tax assets:

 

  

 

  

Accrued expense

$

2,124

$

8,208

Amortization

 

52,532

 

87,998

Federal tax credits

 

174,802

 

142,595

State tax credits

 

9,787

 

8,054

Federal net operating losses

 

69,957

 

76,589

State net operating losses

 

10,316

 

9,159

Foreign net operating losses

 

4,837

 

3,316

Capitalized research and development costs

 

110,219

 

241

Share based compensation and other

 

27,054

 

15,273

Liability for sale of future royalties

185,589

148,503

Noncash interest expense

30,160

26,040

Other comprehensive loss

 

(719)

 

143

Total gross deferred tax assets

 

676,658

 

526,119

Less valuation allowance

 

(672,172)

 

(525,570)

Total deferred tax assets, net of valuation allowance

$

4,486

$

549

Deferred tax liabilities:

 

  

 

  

Depreciation

$

(4,486)

$

(549)

Indefinite lived intangible

 

(102,834)

 

(137,110)

Total gross deferred tax liabilities

 

(107,320)

 

(137,659)

Net deferred tax assets (liabilities)

$

(102,834)

$

(137,110)

Schedule of unrecognized tax benefits

A reconciliation of the gross amount of unrecognized tax benefits, excluding accrued interest and penalties, is as follows:

Unrecognized Tax Benefits

Balance at December 31, 2021

27,217

Additions based on tax positions related to the current year

 

Balance at December 31, 2022

$

27,217